We conducted immunohistochemical analyses to explore the expression patterns of EMP2 protein across various stages of liver disease, ranging from normal liver tissue to hepatocellular carcinoma, using a comprehensive liver disease tissue microarray. This evidence concerns the gene EMP2 and hepatocellular carcinoma.